Related references
Note: Only part of the references are listed.Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals
Tao Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression
Xiong Ying et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer
Sanjay Mishra et al.
CANCER LETTERS (2015)
Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2
Zhi-Sheng Zhang et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers
Ping Wang et al.
CLINICAL LUNG CANCER (2015)
Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis
Jie Bu et al.
DISEASE MARKERS (2015)
Apaf1 inhibition promotes cell recovery from apoptosis
Anna Gortat et al.
PROTEIN & CELL (2015)
A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group
Brian D. Kelly et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
Bo Tang et al.
SCIENTIFIC REPORTS (2015)
MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
A. Y. Jia et al.
BRITISH JOURNAL OF CANCER (2014)
Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
Zhu-qing Zhang et al.
DIAGNOSTIC PATHOLOGY (2014)
Diagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysis
Yang Wang et al.
GENE (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma
Burcu Gurer Giray et al.
MOLECULAR BIOLOGY REPORTS (2014)
A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus
Youwen Tan et al.
PLOS ONE (2014)
Novel Point and Combo-Mutations in the Genome of Hepatitis B Virus-Genotype D: Characterization and Impact on Liver Disease Progression to Hepatocellular Carcinoma
Somenath Datta et al.
PLOS ONE (2014)
Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133
Stella Chai et al.
ONCOTARGET (2014)
Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases
Yong Jiang et al.
SCIENTIFIC REPORTS (2014)
A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages
Brice Lagrange et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Verena Koeberle et al.
EUROPEAN JOURNAL OF CANCER (2013)
Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis
Shivaprasad Shwetha et al.
SCIENTIFIC REPORTS (2013)
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Kai Zhu et al.
BIOMARKER RESEARCH (2013)
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Colin C. Pritchard et al.
CANCER PREVENTION RESEARCH (2012)
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Yoshito Tomimaru et al.
JOURNAL OF HEPATOLOGY (2012)
MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma
Rui-Jun Lin et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Jipeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
Peng Qi et al.
PLOS ONE (2011)
miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7
Yanqin Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
miR-126 functions as a tumour suppressor in human gastric cancer
Runhua Feng et al.
CANCER LETTERS (2010)
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
R. I. Aqeilan et al.
CELL DEATH AND DIFFERENTIATION (2010)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
Cancer biomarker profiling with microRNAs
Stefanie S. Jeffrey
NATURE BIOTECHNOLOGY (2008)
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas
Jian-Hua Luo et al.
HEPATOLOGY (2006)
Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis:: ultrasound and clinical features in 153 consecutive patients
GL Rapaccini et al.
LIVER INTERNATIONAL (2004)
α-fetoprotein and ultrasonography screening for hepatocellular carcinoma
B Daniele et al.
GASTROENTEROLOGY (2004)
The natural history of chronic hepatitis B virus infection
BJ McMahon
SEMINARS IN LIVER DISEASE (2004)
Risk factors for hepatocellular carcinoma in patients with cirrhosis
SA Sarbah et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
BJ McMahon et al.
HEPATOLOGY (2000)